Sun Protection Factor (SPF) Efficacy Assay

Bayer

Status: Completed

Conditions: Sunscreen Agents

Treatments: Drug: SPF 15 Control; Drug: BAY987516

Study type: Interventional

Funder types: Industry

Identifiers

NCT02885805

18322

Details and patient eligibility

About

Evaluation of the effectiveness of a sunscreen product by determining its Sun Protection Factor (SPF) on the skin of human subjects.

Enrollment: 11 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Fitzpatrick Skin Type I, II and/or 111 for UVB testing; Fitzpatrick Skin Type II, 111 and/or IV for UVA testing.
• Sex: Male or female.
• Age: 18-70 years.
• Good health as determined from the HRL SHF.
• Signed and dated lnformed Consent Form.
• Signed and dated HIPAA Form.
• An unambiguous MED or MPPD

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

11 participants in 1 patient group

SPF evaluation + Control

Experimental group

Description:

Fair-skinned subjects in good health with Skin Types I, II or III.

Treatment:

Drug: SPF 15 Control

Drug: BAY987516